Evidence map›Paper›PMID 37781153›Full record

ArticleCanadian journal of kidney health and disease2023

The Quality of Discharge Summaries After Acute Kidney Injury.

Cameron Giles, Milica Novakovic, Wilma Hopman, Erin F Barreto, William Beaubien-Souligny, Peter Birks, Javier A Neyra, Ron Wald, Samuel A Silver

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Cameron GilesDepartment of Medicine, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0002-1009-4392
Milica NovakovicDepartment of Family Medicine, McMaster University, Hamilton, ON, Canada.
Wilma HopmanKingston General Hospital Research Institute, Kingston Health Sciences Centre, ON, Canada.
Erin F BarretoMayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-0996-1487
William Beaubien-SoulignyDivision of Nephrology, Centre Hospitalier de l'Université de Montréal, QC, Canada.ORCID https://orcid.org/0000-0003-3030-8703
Peter BirksDivision of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, Canada.
Javier A NeyraDivision of Nephrology, Department of Medicine, The University of Alabama at Birmingham, AL, USA.
Ron WaldDivision of Nephrology, St. Michael's Hospital, University of Toronto, ON, Canada.
Samuel A SilverDivision of Nephrology, Department of Medicine, Queen's University and Kingston Health Sciences Centre, ON, Canada.ORCID https://orcid.org/0000-0002-1843-6131
McMaster University · CACentre Hospitalier de l’Université de Montréal · CAKingston General Hospital · CAMayo Clinic in Arizona · USQueen's University · CASt. Michael's Hospital · CAUniversity of Alabama at Birmingham · USUniversity of British Columbia · CA

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI ConsortiumU01DK129989 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Javier A. Neyra, Edward D Siew · 2021 to 2026
$4.7M
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention TrialR01DK128208 · NIDDK · TUFTS MEDICAL CENTER · PI DREW, DAVID ALAN, NEYRA, JAVIER A. · 2021 to 2025
$1.6M
Beta-lactam individualization for critically ill patientsK23AI143882 · NIAID · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2020 to 2024
$986k
Enhanced kidney follow-up for AKI survivors in Care Transitions (the ACT Study)R03HS028060 · AHRQ · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2021 to 2022
$100k
AHRQ HHS R03 HS028060NIAID NIH HHS K23 AI143882NIDDK NIH HHS P30 DK079337NIDDK NIH HHS R01 DK128208NIDDK NIH HHS U01 DK129989
6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) increases the risk of hospital readmission, chronic kidney disease, and death. Therefore, effective communication in discharge summaries is essential for safe transitions of care. Objective: The objectives of this study were to determine the quality of discharge summaries in AKI survivors and identify predictors of higher quality discharge summaries. Design: Retrospective chart review. Setting: Tertiary care academic center in Ontario, Canada. Patients: We examined the discharge summary quality of 300 randomly selected adult patients who survived a hospitalization with AKI at our tertiary care hospital, stratified by AKI severity. We included 150 patients each from 2015 to 2016 and 2018 to 2019, before and after introduction of a post-AKI clinic in 2017. Measurements: We reviewed charts for 9 elements of AKI care to create a composite score summarizing discharge summary quality. Methods: We used multivariable logistic regression to identify predictors of discharge summary quality. Results: The median discharge summary composite score was 4/9 (interquartile range, 2-6). The least frequently mentioned elements were baseline creatinine (n = 55, 18%), AKI-specific follow-up labs (n = 66, 22%), and medication recommendations (n = 80, 27%). The odds of having a higher quality discharge summary (composite score ≥4/9) was greater for every increase in baseline creatinine of 25 μmol/L (adjusted odds ratio [aOR]: 1.27; 95% confidence interval [CI]: 1.03, 1.56), intrarenal etiology (aOR: 2.32; 95% CI: 1.26, 4.27), and increased AKI severity (stage 2 aOR: 2.57; 95% CI: 1.35, 4.91 and stage 3 aOR: 3.36; 95% CI: 1.56, 7.22). There was no association between discharge summary quality and the years before and after introduction of a post-AKI clinic (aOR: 0.77; 95% CI: 0.46, 1.29). Limitations: The single-center study design limits generalizability. Conclusions: Most discharge summaries are missing key AKI elements, even in patients with severe AKI. These gaps suggest several opportunities exist to improve discharge summary communication following AKI.

Indexed as

acute kidney injurydischarge summaryhospitalization

Identifiers

PMID37781153
PMCPMC10540581
OpenAlexW4387146734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.